Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
Morselli Gysi D, do Valle Í, Zitnik M, Ameli A, Gan X, Varol O, Ghiassian SD, Patten JJ, Davey RA, Loscalzo J, Barabási AL. · 2021
Read Network medicine framework for identifying drug-repurposing opportunities for COVID-19. by Morselli Gysi D, do Valle Í, Zitnik M, Ameli A, Gan X, Varol O, Ghiassian SD, Patten JJ, Davey RA, Loscalzo J, Barabási AL. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8126852.txt.
Description
Morselli and co-authors build a network medicine pipeline to rank old drugs against COVID-19. New drug development takes a decade, far too slow here. Algorithms offered rival shortcuts with unproven accuracy. The team ran AI, network diffusion, and proximity methods side by side. They ranked 6,340 approved drugs for expected effect. Then they did what most studies skip: a large lab check.
The lab screened 918 of the ranked drugs experimentally. That ground truth exposed how each method truly performed. A consensus algorithm blended the methods and beat them singly. Top-ranked drugs then faced live virus in human cells. Six drugs cut viral infection in those tests. Four of them could be repurposed for patients right away. The strategy, the authors stress, travels beyond COVID-19. Neglected diseases with no drug pipeline could use it tomorrow.
Catalog record
| CREATOR | Morselli Gysi D, do Valle Í, Zitnik M, Ameli A, Gan X, Varol O, Ghiassian SD, Patten JJ, Davey RA, Loscalzo J, Barabási AL. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |